Skip to main content
SpringerLink
Log in

Introduction

  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bornstein MB, Miller AI, Teitelbaum D, et al (1982) Multiple sclerosis: trial of a synthetic polypeptide. Ann Neurol 11: 317–319

    Article  CAS  PubMed  Google Scholar 

  2. Bornstein MB, Miller A, Slagle S, et al (1987) A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317:408–414

    Article  CAS  PubMed  Google Scholar 

  3. Bornstein MB, Miller A, Slagle S, et al (1991) A placebo-controlled, doubleblind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41:533–539

    CAS  PubMed  Google Scholar 

  4. Johnson KP, Brooks BR, Cohen JA, et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45:1268–1276

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Maryland, Baltimore, Maryland, USA

    Kenneth P. Johnson

Authors
  1. Kenneth P. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, K.P. Introduction. J Neurol 243 (Suppl 1), S1–S2 (1996). https://doi.org/10.1007/BF00873694

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00873694

Search

Navigation